Condition
Post COVID Condition
Total Trials
7
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
14%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
7Total
Not Applicable (3)
P 2 (3)
P 3 (1)
Trial Status
Enrolling By Invitation2
Completed2
Not Yet Recruiting1
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT07530757Not ApplicableNot Yet RecruitingPrimary
SuperCAP Program to Improve Cognition and Daily Functioning in Post-COVID-19 Condition
NCT07298005Phase 2RecruitingPrimary
Sonlicromanol in Post-COVID
NCT05513560Phase 2Completed
RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine
NCT07280572Phase 3Enrolling By InvitationPrimary
RECLAIM Adaptive Platform Trial for PCC Treatments
NCT06689345Not ApplicableEnrolling By InvitationPrimary
Effect of Non-Invasive Neuromodulation on Primary Chronic Pain, Including Post-COVID-19
NCT04842448Phase 2Completed
Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome
NCT05918965Not ApplicableUnknown
Vagus Stimulation in Female Long COVID Patients.
Showing all 7 trials